InspireMD Inc
XBER:II2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
InspireMD Inc
XBER:II2
|
IL |
|
Ascendis Pharma A/S
NASDAQ:ASND
|
DK |
|
Crane NXT Co
F:P8Q
|
US |
|
Tokyo Century Corp
F:59O
|
JP |
|
Arvind Ltd
NSE:ARVIND
|
IN |
|
Q
|
Quinstreet Inc
SWB:5Q8
|
US |
|
Lintec Corp
F:57T
|
JP |
|
Q
|
Quinstreet Inc
XBER:5Q8
|
US |
|
Taboola.com Ltd
F:1FY
|
US |
|
American International Group Inc
F:AINN
|
US |
|
Repay Holdings Corp
F:0YR
|
US |
|
B.P. Marsh & Partners PLC
LSE:BPM
|
UK |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
US |
|
S
|
SF Real Estate Investment Trust
F:8ET
|
HK |
|
B
|
Basf Se
BMV:BASN
|
DE |
|
M
|
Moelis & Co
F:17M
|
US |
|
C
|
Canadian Natural Resources Ltd
F:CRC
|
CA |
|
A
|
Andlauer Healthcare Group Inc
F:3LT
|
CA |
|
Q
|
Quinstreet Inc
F:5Q8
|
US |
|
C
|
Canadian Natural Resources Ltd
XMUN:CRC
|
CA |
|
A
|
Ascendis Pharma A/S
F:A71
|
DK |
Dividends
Dividend Yield
InspireMD Inc
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
InspireMD Inc
II2 have decreased by 0%.
Payout Ratio
InspireMD Inc
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for II2 is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
II2 Price
InspireMD Inc
| Average Annual Return |
N/A
|
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown |
N/A
|
| Market Capitalization | 39.5m EUR |
| Shares Outstanding | 8 080 000 |
| Percentage of Shares Shorted |
N/A
|
